Form 8-K - Current report:
SEC Accession No. 0001564590-20-014794
Filing Date
2020-04-01
Accepted
2020-04-01 16:30:24
Documents
3
Period of Report
2020-04-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eigr-8k_20200401.htm 8-K 33152
2 EX-99.1 eigr-ex991_6.htm EX-99.1 22611
3 GRAPHIC gedwv05ldloo000001.jpg GRAPHIC 4393
  Complete submission text file 0001564590-20-014794.txt   63113
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

EIN.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 20765781
SIC: 2836 Biological Products, (No Diagnostic Substances)